Abstract
Breast implant-associated anaplastic large cell lymphoma (ALCL) is a rare new clinical entity. The incidence is 0.3 % per 100,000 women per year. Patients present with non-specific implant-related complications resulting in delayed diagnosis. We present such a case to raise awareness and discuss management. A 48-year-old female presented with a 3-month history of left breast pain and swelling. She had undergone multiple bilateral augmentations 8 years previously. Triple assessment revealed a seroma, and a magnetic resonance imaging scan excluded implant rupture. Cytology showed a typical cells with mitotic activity which lead to removal of implants and a left capsulectomy. Final histology revealed an anaplastic lymphoma kinase (ALK) negative ALCL confined to the capsule. A computerised tomography scan and bone marrow biopsy excluded systemic disease, but due to later identified B symptoms, she received CHOP chemotherapy under the care of the haematologists. ALK-negative ALCL is associated with breast implants, and any persistent late onset seroma or breast symptoms should raise the suspicion of ALK-negative ALCL as a differential diagnosis. The recommended treatment is surgical removal of the implant including a full capsulectomy, highlighting the suspicion of ALCL to the pathologist. Exclusion of systematic disease is also recommended in all patients, and the need for adjuvant therapy should be addressed on an individual case basis. For disease confined to the capsule, adjuvant chemoradiotherapy is not needed.
Level of Evidence V
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors http://www.springer.com/00266.
Similar content being viewed by others
References
Keech JA, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100(2):554–555
Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ et al (2012) Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol 36(7):1000–1008
Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ (2009) Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 133(9):1383–1390
Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG et al (2011) ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer 11(5):283–296
Popplewell L, Thomas SH, Huang Q, Chang KL, Forman SJ (2011) Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymph 52(8):1481–1487
Farace F, Bulla A, Marongiu F, Campus G, Tanda F, Lissia A et al (2013) Anaplastic large cell lymphoma of the breast arising around mammary implant capsule: an Italian report. Aesthet Plast Surg 37(3):567–571
Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ (2008) Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol 32(9):1299–1309
Shim E, Song SE, Seo BK, Kim Y-S, Son GS (2013) Lymphoma affecting the breast: a pictorial review of multimodal imaging findings. J Breast Cancer 16(3):254–265
De Silva IM, Teague JA, Blake WE (2013) Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option. J Plast Reconstr Aesthet Surg 66(12):1773–1776
Kim B, Roth C, Young VL, Chung KC, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg 128(3):629–639
Kirkpatrick CJ, Alves A, Kohler H, Kriegsmann J, Bittinger F, Otto M et al (2000) Biomaterial-induced sarcoma: a novel model to study preneoplastic change. Am J Pathol 156(4):1455–1467
Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 127(6):2141–2150
Thompson PA, Prince HM (2013) Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis. Curr Hematol Malig Rep 8(3):196–210
George EV, Pharm J, Houston C, Al-Quran S, Brian G, Dong H et al (2013) Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol 6(8):1631–1642
Carty MJ, Pribaz JJ, Antin JH, Volpicelli ER, Toomey CE, Farkash EA et al (2011) A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg 128(3):112e–118e
Bautista-Quach MA, Nademanee A, Weisenburger DD, Chen W, Kim YS (2013) Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules. Clin Breast Cancer 13(6):492–495
Hall-Findlay EJ (2011) Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg 127(1):56–66
Spear SL, Rottman SJ, Glicksman C, Brown M, Al-Attar A (2012) Late seromas after breast implants: theory and practice. Plast Reconstr Surg 130(2):423–435
Medicines and Healthcare products Regulatory Agency (2014) Medical device alert: breast implants. All types, makes and models (MDA/2014/027). http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON433919. Accessed 13 Jan 2015
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, MJ., Brown, H., Murrin, R. et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report and Literature Review. Aesth Plast Surg 39, 391–395 (2015). https://doi.org/10.1007/s00266-015-0463-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-015-0463-2